Author:
Reich-Slotky Ronit,Hsu Yen-Michael S.,Schwartz Joseph
Reference22 articles.
1. Guidance for Industry: Eligibility Determination for Donors of Human Cell, Tissues, and Cellular and Tissue Based Products (HCT/Ps), 2007. Available from: http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/tissue/ucm091345.pdf.
2. Cellular biology of hematopoiesis;Schoemans,2009
3. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings;Wang;Biol. Blood Marrow Transplant.,2008
4. Factors that influence collection and engraftment of autologous peripheral-blood stem cells;Bensinger;J. Clin. Oncol.,1995
5. Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation;Chabannon;Leukemia,2003